FDA stated in written correspondence for a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably ...

Data privacy experts are urging consumers to be proactive about protecting their data on the site. Here's how to delete yours ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Intensity Therapeutics, Inc. (INTS – Research ...

Servier announces a strategic worldwide licensing agreement for Black Diamond Therapeutics' BDTX-4933 for solid tumors for an ...

Researchers from Mass General Brigham developed olfactory tests—in which participants sniff odor labels that have been placed on a card—to assess people’s ability to discriminate, identify and ...

Q4 2024 Earnings Call Transcript March 20, 2025 Abeona Therapeutics Inc. beats earnings expectations. Reported EPS is $-0.24, ...

Q4 2024 Earnings Call Transcript March 20, 2025 Cognition Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

Frederic L.W.V.J. Schaper, MD, PhD , director of Epilepsy Network Mapping at the Center for Brain Circuit Therapeutics at ...

A young person with Duchenne muscular dystrophy died following treatment with the recently approved gene therapy ...

Once valued at $6 billion, genetic testing company 23andMe filed for Chapter 11 bankruptcy protection on Sunday.

Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide clinically meaningful benefit to CF patients. Topline ...